Abstract

Introduction: The role of neuraminidases in cardiovascular disease has recently gained increasing attention. However, the association between neuraminidase gene polymorphisms and heart failure (HF) has not yet been investigated. Methods and Results: Genotyping of nine single-nucleotide polymorphisms (SNPs) in the NEU2/NEU3/NEU4 genes was performed in 610 HF patients and 600 healthy controls from the Southwest Han Chinese population using TaqMan SNP Genotyping Assay. Individuals carrying the A allele of rs11545301 had decreased risk of HF (additive model: OR = 0.704, 95% CI = 0.511–0.97; p = 0.032). However, the C allele of rs2293763 increased the risk of HF in the recessive model (OR = 1.486, 95% CI = 1.095–2.012; p = 0.011). Rs2233384, rs2233394, and rs2293763 were significantly associated with the mortality risk of HF in the dominant model, both with and without adjustment for conventional risk factors (HR = 0.686, 95% CI = 0.52–0.906, p = 0.008 for rs2233384, HR = 1.357, 95% CI = 1.035–1.78, p = 0.027 for rs2233384, and HR = 0.76, 95% CI = 0.592–0.975, p = 0.031 for rs2293763). Conclusion: Our findings demonstrated the association between a series of variants in NEU2/NEU4 genes and the risk or prognosis of HF in the Han Chinese population. These data suggested an important role of NEU2 and NEU4 in the pathogenesis of HF.

© 2022 The Author(s). Published by S. Karger AG, Basel

References Komal S, Zhang LR, Han SN. Potential regulatory role of epigenetic RNA methylation in cardiovascular diseases. Biomed Pharmacother. 2021;137:111376. Kitsiou S, Vatani H, Paré G, Gerber BS, Buchholz SW, Kansal MM, et al. Effectiveness of mobile health technology interventions for patients with heart failure: systematic review and meta-analysis. Can J Cardiol. 2021;37(8):1248–59. Hu D, Li S, Hu S, Sun Y, Xiao L, Li C, et al. A common missense variant in OMA1 associated with the prognosis of heart failure. Cardiovasc Drugs Ther. 2020;34(3):345–56. Yang H, Lu L, Chen X. An overview and future prospects of sialic acids. Biotechnol Adv. 2021;46:107678. Colley KJ, Kitajima K, Sato C. Polysialic acid: biosynthesis, novel functions and applications. Crit Rev Biochem Mol Biol. 2014;49(6):498–532. Rodriguez E, Boelaars K, Brown K, Eveline Li RJ, Kruijssen L, Bruijns SCM, et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat Commun. 2021;12(1):1270. Pally D, Pramanik D, Hussain S, Verma S, Srinivas A, Kumar RV, et al. Heterogeneity in 2, 6-linked sialic acids potentiates invasion of breast cancer epithelia. ACS Cent Sci. 2021;7(1):110–25. Dědová T, Braicu EI, Sehouli J, Blanchard V. Sialic acid linkage analysis refines the diagnosis of ovarian cancer. Front Oncol. 2019;9:261. Chen X, Varki A. Advances in the biology and chemistry of sialic acids. ACS Chem Biol. 2010;5(2):163–76. Wasik BR, Barnard KN, Parrish CR. Effects of sialic acid modifications on virus binding and infection. Trends Microbiol. 2016;24(12):991–1001. Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M, et al. Essentials of glycobiology. 3rd ed. New York: Cold Spring Harbor; 2015. Bonten E, van der Spoel A, Fornerod M, Grosveld G, d’Azzo A. Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev. 1996;10(24):3156–69. Monti E, Preti A, Rossi E, Ballabio A, Borsani G. Cloning and characterization of NEU2, a human gene homologous to rodent soluble sialidases. Genomics. 1999;57(1):137–43. Wada T, Yoshikawa Y, Tokuyama S, Kuwabara M, Akita H, Miyagi T. Cloning, expression, and chromosomal mapping of a human ganglioside sialidase. Biochem Biophys Res Commun. 1999;261(1):21–7. Miyagi T, Wada T, Iwamatsu A, Hata K, Yoshikawa Y, Tokuyama S, et al. Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides. J Biol Chem. 1999;274(8):5004–11. Comelli EM, Amado M, Lustig SR, Paulson JC. Identification and expression of Neu4, a novel murine sialidase. Gene. 2003;321:155–61. Monti E, Bassi MT, Bresciani R, Civini S, Croci GL, Papini N, et al. Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene family. Genomics. 2004;83(3):445–53. Heimerl M, Sieve I, Ricke-Hoch M, Erschow S, Battmer K, Scherr M, et al. Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages. Basic Res Cardiol. 2020;115(6):62. Zhang L, Wei TT, Li Y, Li J, Fan Y, Huang FQ, et al. Functional metabolomics characterizes a key role for N-acetylneuraminic acid in coronary artery diseases. Circulation. 2018;137(13):1374–90. Piccoli M, Conforti E, Varrica A, Ghiroldi A, Cirillo F, Resmini G, et al. NEU3 sialidase role in activating HIF-1α in response to chronic hypoxia in cyanotic congenital heart patients. Int J Cardiol. 2017;230:6–13. Demina EP, Smutova V, Pan X, Fougerat A, Guo T, Zou C, et al. Neuraminidases 1 and 3 trigger atherosclerosis by desialylating low-density lipoproteins and increasing their uptake by macrophages. J Am Heart Assoc. 2021;10(4):e018756. Fanzani A, Colombo F, Giuliani R, Preti A, Marchesini S. Insulin-like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy. FEBS J. 2006;273(16):3709–21. Fanzani A, Giuliani R, Colombo F, Rossi S, Stoppani E, Martinet W, et al. The enzymatic activity of sialidase Neu2 is inversely regulated during in vitro myoblast hypertrophy and atrophy. Biochem Biophys Res Commun. 2008;370(2):376–81. Fanzani A, Giuliani R, Colombo F, Zizioli D, Presta M, Preti A, et al. Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells. FEBS Lett. 2003;547(1–3):183–8. Fanzani A, Colombo F, Giuliani R, Preti A, Marchesini S. Cytosolic sialidase Neu2 upregulation during PC12 cells differentiation. FEBS Lett. 2004;566(1–3):178–82. Luke MM, Berger K, Rowland CM, Catanese JJ, Tong CH, Ross DA, et al. Polymorphisms and noncardioembolic stroke in three case-control studies. Cerebrovasc Dis. 2012;33(1):80–5. Satyavarapu EM, Nath S, Mandal C. Desialylation of Atg5 by sialidase (Neu2) enhances autophagosome formation to induce anchorage-dependent cell death in ovarian cancer cells. Cell Death Discov. 2021;7(1):26. Nath S, Mandal C, Chatterjee U, Mandal C. Association of cytosolic sialidase Neu2 with plasma membrane enhances Fas-mediated apoptosis by impairing PI3K-Akt/mTOR-mediated pathway in pancreatic cancer cells. Cell Death Dis. 2018;9(2):210. Tringali C, Lupo B, Anastasia L, Papini N, Monti E, Bresciani R, et al. Expression of sialidase Neu2 in leukemic K562 cells induces apoptosis by impairing Bcr-Abl/Src kinases signaling. J Biol Chem. 2007;282(19):14364–72. Hasegawa T, Sugeno N, Takeda A, Matsuzaki-Kobayashi M, Kikuchi A, Furukawa K, et al. Role of Neu4L sialidase and its substrate ganglioside GD3 in neuronal apoptosis induced by catechol metabolites. FEBS Lett. 2007;581(3):406–12. Finlay TM, Abdulkhalek S, Gilmour A, Guzzo C, Jayanth P, Amith SR, et al. Thymoquinone-induced Neu4 sialidase activates NFκB in macrophage cells and pro-inflammatory cytokines in vivo. Glycoconj J. 2010;27(6):583–600. Article / Publication Details

First-Page Preview

Received: April 22, 2022
Accepted: June 15, 2022
Published online: June 28, 2022

Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 4

ISSN: 0001-5652 (Print)
eISSN: 1423-0062 (Online)

For additional information: https://www.karger.com/HHE

Figures Tables